Modulating ongoing Th2-cell responses in experimental leishmaniasis

Parasitology Today

Volumn 13, Issue 2, 1997, Pages 76-79

  Nabors, Gary S ^a  

^a Pasteur Merleux Connaught ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE ANTIBODY; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 12; STIBOGLUCONATE SODIUM;

ARTICLE; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNITY; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; T LYMPHOCYTE;

LEISHMANIA MAJOR; MURINAE;

EID: 0031081724     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(96)10078-8     Document Type: Review

References (25)

1. 1 O'Garra, A. and Murphy, K. (1994) Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6, 458-466
2. 2 Heinzel, F.P. et al. (1989) Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. J. Exp. Med. 169, 59-72
3. 3 Sypek, J.P. et al. (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177, 1797-1802
4. 4 Chatelain, R. et al. (1992) IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148, 1182-1187
5. 5 Titus, R.G. et al. (1985) Therapeutic effect of anti-L3T4 monoclonal GK1.5 on cutaneous leishmaniasis in genetically susceptible BALB/c mice. J. Immunol. 135, 2108-2114
6. 6 Carvalho, E.M. et al. (1994) Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol. 152, 5949-5956
7. 7 Fernandez-Guerrero, M.L. et al. (1987) Visceral leishmaniasis in immunocompromised hosts. Am. J. Med. 53, 1098-1102
8. 8 Altes, J. et al. (1991) Visceral leishmaniasis: another HIV-associated opportunistic infection? AIDS 5, 201-207
9. 9 Murray, H.W. et al. (1989) Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. J. Clin. Invest. 83, 1253-1257
10. 10 Parish, C.R. (1972) The relationship between humoral and cell-mediated immunity. Transplant Rev. 13, 35-66
11. 11 Caulada-Benedetti, Z. et al. (1991) Comparison of Th1-and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae. J. Immunol. 146, 1655-1660
12. 12 Bretscher, P.A. et al. (1992) Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257, 539-542
13. 13 Clerici, M. et al. (1994) T cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 8, 1391-1395
14. 14 Nabors, G.S. et al. (1995) Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc. Natl. Acad. Sci. U. S. A. 92, 3142-3146
15. 15 Nabors, G.S. and Farrell, J.P. (1994) Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses. Infect. Immun. 62, 5498-5504
16. 16 Nabors, G.S. and Farrell, J.P. (1996) Successful chemotherapy in experimental leishmaniasis is influenced by the polarity of the T cell response before treatment. J. Infect. Dis. 173, 979-986
17. 17 Berman, J.D. and Wyler, D.J. (1980) An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. J. Infect. Dis. 145, 83-86
18. 18 Nabors, G.S. and Farrell, J.P. (1995) Activity of Pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-γ antibody. Am. J. Trop. Med. Hyg. 53, 55-60
19. 19 Pernis, A. et al. (1995) Lack of Interferon γ receptor β chain and the prevention of interferon γ signaling in Th1 cells. Science 269, 245-247
20. 20 Manetti, R. et al. (1994) Interleukin 12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 clones. J. Exp. Med. 179, 1273-1283
21. 21 Guler, M.L. et al. (1996) Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 271, 984-987
22. 22 Badaro, R. et al. (1990) Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. New Engl. J. Med. 322, 16-21
23. 23 Falcoff, E. et al. (1994) Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-γ and pentavalent antimonial compounds. Trans. R. Soc. Trop. Med. Hyg. 88, 95-97
24. 24 Badaro, R. and Johnson, W.D. (1993) The role of interferon-γ in the treatment of visceral and diffuse cutaneous leishmaniasis. J. Infect. Dis. 167 (Suppl. 1), S13-S17
25. 25 Wenner, C.A. et al. (1996) Roles of IFN-γ and IFN-α in IL-12-induced T helper cell-1 development. J. Immunol. 156, 1442-1447